- Home
- KAVL vs XYLO Comparison
KAVL vs XYLO Comparison
Compare KAVL & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAVL
- XYLO
- Stock Information
- Founded
- KAVL 1998
- XYLO 1999
- Country
- KAVL United States
- XYLO Israel
- Employees
- KAVL N/A
- XYLO N/A
- Industry
- KAVL Medicinal Chemicals and Botanical Products
- XYLO
- Sector
- KAVL Health Care
- XYLO
- Exchange
- KAVL Nasdaq
- XYLO NYSE
- Market Cap
- KAVL 5.6M
- XYLO 6.2M
- IPO Year
- KAVL N/A
- XYLO N/A
- Fundamental
- Price
- KAVL $0.48
- XYLO $5.09
- Analyst Decision
- KAVL
- XYLO
- Analyst Count
- KAVL 0
- XYLO 0
- Target Price
- KAVL N/A
- XYLO N/A
- AVG Volume (30 Days)
- KAVL 1.2M
- XYLO 7.2K
- Earning Date
- KAVL 09-19-2025
- XYLO 09-19-2025
- Dividend Yield
- KAVL N/A
- XYLO N/A
- EPS Growth
- KAVL N/A
- XYLO N/A
- EPS
- KAVL N/A
- XYLO N/A
- Revenue
- KAVL $1,698,426.00
- XYLO $29,858,000.00
- Revenue This Year
- KAVL N/A
- XYLO $279.19
- Revenue Next Year
- KAVL N/A
- XYLO N/A
- P/E Ratio
- KAVL N/A
- XYLO N/A
- Revenue Growth
- KAVL N/A
- XYLO N/A
- 52 Week Low
- KAVL $0.45
- XYLO $2.70
- 52 Week High
- KAVL $1.95
- XYLO $6.67
- Technical
- Relative Strength Index (RSI)
- KAVL 44.22
- XYLO 51.85
- Support Level
- KAVL $0.45
- XYLO $4.91
- Resistance Level
- KAVL $0.51
- XYLO $5.23
- Average True Range (ATR)
- KAVL 0.07
- XYLO 0.15
- MACD
- KAVL -0.00
- XYLO 0.02
- Stochastic Oscillator
- KAVL 5.83
- XYLO 69.57
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.